Literature DB >> 26634570

Treatment of gastrointestinal autonomic neuropathy.

Hans Törnblom1.   

Abstract

The symptoms caused by gastrointestinal autonomic neuropathy in diabetes mellitus is important to highlight since it affects a large proportion of people with diabetes, regardless of whether this is type 1 or type 2. Gastroparesis and general signs of bowel dysfunction, such as constipation, diarrhoea and abdominal pain are most often encountered and involve both pharmacological and non-pharmacological treatment options. This mini-review summarises a presentation given at the 'Diagnosis and treatment of autonomic diabetic neuropathy in the gut' symposium at the 2015 annual meeting of the EASD. It is accompanied by another mini-review on a topic from this symposium (by Azpiroz and Malagelada, DOI: 10.1007/s00125-015-3831-1 ) and a commentary by the Session Chair, Péter Kempler (DOI: 10.1007/s00125-015-3826-y ).

Entities:  

Keywords:  Abdominal pain; Autonomic neuropathy; Constipation; Diarrhoea; Gastric electrical stimulation; Gastroparesis

Mesh:

Year:  2015        PMID: 26634570     DOI: 10.1007/s00125-015-3828-9

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  37 in total

1.  Gastric electrical stimulation improves outcomes of patients with gastroparesis for up to 10 years.

Authors:  Richard W McCallum; Zhiyue Lin; Jameson Forster; Katherine Roeser; Qingjiang Hou; Irene Sarosiek
Journal:  Clin Gastroenterol Hepatol       Date:  2010-12-23       Impact factor: 11.382

2.  Characteristics of patients with chronic unexplained nausea and vomiting and normal gastric emptying.

Authors:  Pankaj J Pasricha; Ryan Colvin; Katherine Yates; William L Hasler; Thomas L Abell; Aynur Unalp-Arida; Linda Nguyen; Gianrico Farrugia; Kenneth L Koch; Henry P Parkman; William J Snape; Linda Lee; James Tonascia; Frank Hamilton
Journal:  Clin Gastroenterol Hepatol       Date:  2011-03-11       Impact factor: 11.382

Review 3.  The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis.

Authors:  Pieter Janssen; M Scott Harris; Mike Jones; Tatsuhiro Masaoka; Ricard Farré; Hans Törnblom; Lukas Van Oudenhove; Magnus Simrén; Jan Tack
Journal:  Am J Gastroenterol       Date:  2013-09       Impact factor: 10.864

4.  Imipramine treatment improves cognitive outcome associated with enhanced hippocampal neurogenesis after traumatic brain injury in mice.

Authors:  Xiaodi Han; Jing Tong; Jun Zhang; Arash Farahvar; Ernest Wang; Jiankai Yang; Uzma Samadani; Douglas H Smith; Jason H Huang
Journal:  J Neurotrauma       Date:  2011-05-12       Impact factor: 5.269

5.  A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation.

Authors:  Adil E Bharucha; Phillip Low; Michael Camilleri; Erica Veil; Duane Burton; Yogish Kudva; Pankaj Shah; Tonette Gehrking; Alan R Zinsmeister
Journal:  Gut       Date:  2012-06-07       Impact factor: 23.059

6.  Loperamide in treatment of irritable bowel syndrome--a double-blind placebo controlled study.

Authors:  B Lavö; M Stenstam; A L Nielsen
Journal:  Scand J Gastroenterol Suppl       Date:  1987

7.  Metoclopramide therapy in patients with delayed gastric emptying: a randomized, double-blind study.

Authors:  M S Perkel; C Moore; T Hersh; E D Davidson
Journal:  Dig Dis Sci       Date:  1979-09       Impact factor: 3.199

8.  Management of gastroparesis: beyond basics.

Authors:  Jan Tack; Christophe Vanormelingen
Journal:  Curr Treat Options Gastroenterol       Date:  2014-12

9.  A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis.

Authors:  R W McCallum; D A Ricci; H Rakatansky; J Behar; J B Rhodes; G Salen; J Deren; A Ippoliti; H W Olsen; K Falchuk
Journal:  Diabetes Care       Date:  1983 Sep-Oct       Impact factor: 19.112

10.  Effect of prucalopride on symptoms of chronic constipation.

Authors:  J Tack; V Stanghellini; D Dubois; A Joseph; L Vandeplassche; R Kerstens
Journal:  Neurogastroenterol Motil       Date:  2013-09-20       Impact factor: 3.598

View more
  2 in total

1.  Type 1 diabetic patients with peripheral neuropathy have pan-enteric prolongation of gastrointestinal transit times and an altered caecal pH profile.

Authors:  Adam D Farmer; Anne Grave Pedersen; Birgitte Brock; Poul Erik Jakobsen; Jesper Karmisholt; Sahar D Mohammed; S Mark Scott; Asbjørn Mohr Drewes; Christina Brock
Journal:  Diabetologia       Date:  2017-01-20       Impact factor: 10.122

Review 2.  Diabetic Enteropathy: From Molecule to Mechanism-Based Treatment.

Authors:  Theresa Meldgaard; Søren Schou Olesen; Adam D Farmer; Klaus Krogh; Anne Astrid Wendel; Birgitte Brock; Asbjørn Mohr Drewes; Christina Brock
Journal:  J Diabetes Res       Date:  2018-09-16       Impact factor: 4.011

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.